SPRI | Psychopharmacology And Pregnancy: Treatment Efficacy, Risks, And Guidelines (2014 EN)

Discussion in 'Medicine' started by Kanka, Aug 4, 2019.

  1. Kanka

    Kanka Well-Known Member Loyal User

    Messages:
    16,047
    Likes Received:
    449
    Trophy Points:
    83
    [​IMG]

    Author: Megan Galbally (Editor), Martien Snellen (Editor), Andrew Lewis (Editor)
    Full Title: Psychopharmacology And Pregnancy: Treatment Efficacy, Risks, And Guidelines
    Publisher: Springer; Softcover reprint of the original 1st ed. 2014 edition (August 22, 2016)
    Year: 2014
    ISBN-13: 9783642545627 (978-3-642-54562-7), 9783642545610 (978-3-642-54561-0), 9783662523483 (978-3-662-52348-3)
    ISBN-10: 3642545629, 3642545610, 3662523485
    Pages: 232
    Language: English
    Genre: Medicine: Psychiatry
    File type: EPUB (True), PDF (True)
    Quality: 10/10
    Price: 53.49 €


    This book examines the role of psychopharmacological treatment in a range of disorders that may be encountered during pregnancy, including major depressive disorders, anxiety disorders, bipolar affective disorder, schizophrenia, eating disorders and substance abuse. The natural history of each condition pre and post-partum is analyzed and the evidence for the efficacy of drug treatments, evaluated. Special attention is paid to the potential dangers of different treatment options for both mother and fetus, covering risks of malformation, pregnancy and obstetric risks, neonatal risks and possible long-term consequences. The risks of not treating a particular condition are also analyzed. On the basis of the available evidence, management guidelines are provided that additionally take into account non-pharmacological options. Closing chapters consider the value of complementary and alternative medicine and ECT and explore future research directions.

    -------------
     
    Last edited by a moderator: Dec 3, 2019